ED Disposition for Resolved Hypoglycemia
Patients with resolved hypoglycemia can be safely discharged from the ED if they meet specific criteria, but those taking sulfonylureas or long-acting insulin require more cautious evaluation and may benefit from observation or admission.
Key Disposition Decision Points
Safe for Discharge
Patients may be discharged if ALL of the following are met:
- Blood glucose normalized (>70 mg/dL or 3.9 mmol/L) and remains stable after treatment 1
- Return to baseline mental status within 5-10 minutes of glucose correction 1
- Able to tolerate oral intake and consume a meal/snack to prevent recurrence 2, 3
- Taking insulin alone (particularly if short-acting preparations) 4
- Identifiable and correctable cause (e.g., missed meal, excessive exercise)
- Reliable follow-up available within days
- Patient/family educated on hypoglycemia recognition and management
Require Admission or Extended Observation
Activate EMS or admit if:
- Unable to swallow or maintain oral intake 1
- Seizure occurred during hypoglycemic episode 1
- No improvement within 10 minutes of oral glucose administration 1
- Recurrent hypoglycemia in ED despite treatment 2
- Blood glucose remains <55 mg/dL despite intervention 4
Strong consideration for admission:
- Sulfonylurea-induced hypoglycemia (15.8% return rate vs 2.8% for insulin alone) 4
- Long-acting insulin use with unclear precipitant 4, 5
- Age ≥65 years (odds ratio 5.7-7.9 for requiring hospitalization) 5
- ≥3 prior hypoglycemic episodes 5
- Concurrent infection or acute renal failure 6
- No documented diabetes medications (suggests possible factitious or other serious cause) 5
Critical Discharge Instructions
Written discharge instructions must include (current practice is inadequate in 70-80% of cases) 5:
- Frequent blood glucose monitoring - check before meals and bedtime for 48-72 hours
- Medication dose adjustment - reduce insulin/sulfonylurea dose by 20-50% pending outpatient follow-up
- Avoid recurrent hypoglycemia - specific triggers to avoid
- Check glucose before driving - mandatory safety measure
- Obtain glucagon emergency kit if not already prescribed 7
- Consume complex carbohydrates/protein if >1 hour until next meal 2
Medication-Specific Risk Stratification
Higher Risk (Consider Observation/Admission)
- Sulfonylureas: Longer half-lives cause prolonged hypoglycemia risk; 3.5x odds of admission 5
- Long-acting insulin (glargine, detemir, degludec): All 7 patients with recurrent hypoglycemia in one study were on long-acting preparations 4
- Combination therapy (insulin + oral agents): 9.1% return rate 4
Lower Risk (Safe for Discharge with Appropriate Instructions)
- Short/rapid-acting insulin alone: 2.8% return rate within 48 hours 4
- Metformin or other non-secretagogue oral agents: Not associated with recurrent hypoglycemia
Follow-Up Requirements
- Outpatient appointment within 1 week (ideally 48-72 hours for high-risk patients) 8
- Primary care provider notification at discharge 5
- Diabetes education referral if not previously completed 2, 9
- Consider continuous glucose monitoring for patients with hypoglycemia unawareness 2, 3
Common Pitfalls to Avoid
- Discharging sulfonylurea patients too quickly - these require 12-24 hour observation due to prolonged drug effect
- Inadequate written instructions - verbal education alone is insufficient 5
- Failure to adjust medications - 73% of discharge instructions omit dose adjustment recommendations 5
- Not prescribing glucagon - all high-risk patients should have emergency glucagon available 3, 7
- Ignoring age as risk factor - elderly patients (≥65) have significantly higher admission rates and complications 5
Evidence Quality Note
The 2024 AHA/Red Cross First Aid Guidelines 1 provide the most current recommendations for acute hypoglycemia management and disposition criteria. Research data consistently shows that 5.1-5.4% of discharged patients return within 48-72 hours 6, 10, 4, with sulfonylurea use being the strongest predictor of recurrence requiring repeat ED evaluation.